Grifols SA (GRFS)
9.545
+0.48
(+5.24%)
USD |
NASDAQ |
Nov 14, 16:00
9.545
0.00 (0.00%)
After-Hours: 17:42
Grifols Debt to Equity Ratio: 0.00 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.00 |
| June 30, 2024 | 1.700 |
| December 31, 2023 | 1.546 |
| September 30, 2023 | 1.805 |
| June 30, 2023 | 1.866 |
| December 31, 2022 | 1.425 |
| September 30, 2022 | |
| June 30, 2022 | 1.340 |
| June 30, 2021 | 1.320 |
| March 31, 2021 | 1.359 |
| December 31, 2020 | 1.209 |
| September 30, 2020 | 1.318 |
| June 30, 2020 | 1.175 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 1.320 |
| September 30, 2019 | 1.534 |
| June 30, 2019 | 1.436 |
| March 31, 2019 | 0.075 |
| December 31, 2018 | 0.0017 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 1.547 |
| March 31, 2018 | 0.0471 |
| December 31, 2017 | 1.654 |
| September 30, 2017 | 0.0476 |
| June 30, 2017 | 1.715 |
| Date | Value |
|---|---|
| March 31, 2017 | 0.0417 |
| December 31, 2016 | 1.31 |
| September 30, 2016 | 1.318 |
| June 30, 2016 | 1.368 |
| March 31, 2016 | 1.389 |
| December 31, 2015 | 1.440 |
| September 30, 2015 | 1.423 |
| June 30, 2015 | 1.475 |
| March 31, 2015 | 1.501 |
| December 31, 2014 | 1.588 |
| September 30, 2014 | 1.619 |
| June 30, 2014 | 1.715 |
| March 31, 2014 | 1.707 |
| December 31, 2013 | 1.271 |
| September 30, 2013 | 1.379 |
| June 30, 2013 | 1.440 |
| March 31, 2013 | 1.445 |
| December 31, 2012 | 1.467 |
| September 30, 2012 | 1.525 |
| June 30, 2012 | 1.589 |
| March 31, 2012 | 1.634 |
| December 31, 2011 | 1.761 |
| September 30, 2011 | 1.854 |
| June 30, 2011 | 2.101 |
| March 31, 2011 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Mar 2020
1.866
Maximum
Jun 2023
1.242
Average
1.330
Median
Debt to Equity Ratio Benchmarks
| Cellectis SA | 0.3579 |
| Adaptimmune Therapeutics PLC | 0.2592 |
| Akari Therapeutics PLC | -- |
| Biodexa Pharmaceuticals PLC | -- |
| Verona Pharma PLC | 0.9197 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 22.65B |
| Total Liabilities (Quarterly) | 13.73B |
| Shareholders Equity (Quarterly) | 5.975B |
| Current Ratio | 2.260 |
| Net Debt Paydown Yield | 31.04% |